Analysis of current guidelines for intra-abdominal infections

Journal of Chemotherapy

Volumn 21, Issue SUPPL. 1, 2009, Pages 30-35

  Esposito, S ^a   Leone, S ^a   Carosi, G ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Guidelines; Inadequate antibiotic therapy; Intra abdominal infections

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIFUNGAL AGENT; BETA LACTAMASE INHIBITOR; CEFAZOLIN; CEFOTETAN; CEFOXITIN; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLAVULANIC ACID; DALFOPRISTIN PLUS QUINUPRISTIN; ERTAPENEM; FLUCONAZOLE; GATIFLOXACIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; METRONIDAZOLE; MONOBACTAM DERIVATIVE; MOXIFLOXACIN; NITROIMIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; SULTAMICILLIN; TEICOPLANIN; TIMENTIN; UNINDEXED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT;

ABDOMINAL INFECTION; ANTIBIOTIC THERAPY; CANDIDA; ENTEROCOCCUS; HOSPITAL INFECTION; HUMAN; MONOTHERAPY; PRACTICE GUIDELINE; REVIEW; TREATMENT DURATION; DIGESTIVE SYSTEM DISEASE; INFECTION; MICROBIOLOGY;

ANTI-INFECTIVE AGENTS; DIGESTIVE SYSTEM DISEASES; GUIDELINES AS TOPIC; HUMANS; INFECTION;

EID: 70350503362     PISSN: 1120009X     EISSN: 19739478     Source Type: Journal    
DOI: 10.1179/joc.2009.21.supplement-1.30     Document Type: Review

References (14)

1. Kish MA. Guide to development of practice guidelines. Clin Infect Dis 2001; 32: 851-854.
2. Solomkin JS, Mazuski JE, Baron EJ, et al. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis 2003 ;37:997-1005.
3. Laterre PF, Colardyn F, Delmee M, et al. Antimicrobial therapy for intra-abdominal infections: guidelines from the Infectious Disease Advisory Board (IDAB). Acta Chir Belg 2006; 106:2-21.
4. Mazuski JE, Sawyer RG, Nathens AB, et al. The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: an executive summary. Surg Infect 2002; 3:161-173.
5. Tellado JM, Sitges-Serra A, Barcenilla F, et al. Pautas de tratamiento antibiotico empirico de las infecciones intraabdominales. Emergencias 2005;17: 221-227.
6. Bohnen JM, Solomkin JS, Dellinger EP, et al. Guidelines for clinical care: anti-infective agents for intra-abdominal infection. A Surgical Infection Society policy statement. Arch Surg 1992; 127: 83-89.
7. De Lalla F. Le infezioni endoaddominali: classificazione e microbiologia. Quaderni SUA. 2005.
8. Roehrborn A, Thomas L, Potreck O, et al. The microbiology of postoperative peritonitis. Clin Infect Dis 2001; 33: 1513-1519.
9. Eggimann P, Francioli P, Bille J, et al. Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med 1999; 27: 1066-1072.
10. Baré M, Castells X, Garcia A, et al. Importance of appropriateness of empiric antibiotic therapy on clinical outcomes in intra-abdominal infections. Int J Technol Assess Health Care 2006;22:242-248.
11. Sturkenboom MC, Goettsch WG, Picelli G, et al. Inappropriate initial treatment of secondary intra-abdominal infections leads to increased risk of clinical failure and costs. Br J Clin Pharmacol 2005; 60: 438-443.
12. Montravers P, Gauzit R, Muller C, et al. Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy. Clin Infect Dis 2000;23: 486-494.
13. Hedrick TL, Sawyer RG. Duration of antibiotic therapy for intra-abdominal infections. Infect Med 2004; 21: 506-510.
14. l4 Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Qin Infect Dis 2000; 31 (Suppl 4): 131-138.